Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Merck agrees to buy biopharma firm OncoImmune for $425m

pharmaceutical-technologyNovember 25, 2020

Tag: Merck , OncoImmune , COVID-19

PharmaSources Customer Service